Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mapping the mutational landscape of an avian retrovirus envelope protein across its evolutionary trajectory.

PLoS pathogens·2026
Same author

Marek's disease virus hijacks host nucleotide metabolism via UL23-mediated c-Myc activation.

Veterinary microbiology·2026
Same author

Role of O-linked glycosylation modification on internalization and replication of avian leukosis virus subgroup J.

Veterinary research·2026
Same author

The molecular, antigenic, and pathogenic characterization of novel IBV of GI-22 lineage endemic in China.

Virology·2026
Same author

Factors Influencing Physicians' Perceived Compensation Satisfaction in China: Cross-Sectional Study.

JMIR formative research·2026
Same author

Hemagglutinin-encoded mRNA vaccine confers efficient protection against H3N8 avian influenza virus in mice.

Veterinary microbiology·2025

Related Experiment Video

Updated: Jun 14, 2026

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
09:47

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Published on: February 19, 2016

Polysaccharide surface modified Fe3O4 nanoparticles for camptothecin loading and release.

Aiping Zhu1, Lanhua Yuan, Wenjie Jin

  • 1College of Chemistry and Chemical Engineering, Yangzhou University, Yangzhou 225002, PR China. apzhu@yzu.edu.cn

Acta Biomaterialia
|March 17, 2009
PubMed
Summary

Functional polysaccharides stabilized iron oxide nanoparticles for improved cancer drug delivery. These modified nanoparticles enhanced the anti-cancer activity of camptothecin against liver cancer cells without significant toxicity.

More Related Videos

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

Related Experiment Videos

Last Updated: Jun 14, 2026

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
09:47

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Published on: February 19, 2016

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Cancer Research

Background:

  • Iron oxide nanoparticles (Fe3O4) offer potential in drug delivery but require surface modification for enhanced bioactivity and controlled release.
  • Polysaccharides like chitosan (CS) and its derivatives (OCMCS, NSOCMCS) are biocompatible materials suitable for nanoparticle stabilization.
  • Camptothecin (CPT) is a potent anti-cancer drug with limited clinical use due to poor solubility and side effects.

Purpose of the Study:

  • To stabilize Fe3O4 nanoparticles using functional polysaccharides (CS, OCMCS, NSOCMCS).
  • To investigate the effect of polysaccharide modification on CPT loading, release kinetics, and in vitro anti-cancer activity.
  • To evaluate the cytotoxicity and cellular uptake of the developed drug delivery system.

Main Methods:

  • Fe3O4 nanoparticles were synthesized and stabilized with CS, OCMCS, and NSOCMCS.
  • Camptothecin (CPT) was loaded onto the modified nanoparticles.
  • Particle size, CPT adsorption, CPT release profiles, and bovine serum albumin (BSA) unspecific binding were analyzed.
  • In vitro cytotoxicity and morphological changes in 7721 liver cancer cells were assessed using phase contrast microscopy and cytotoxicity assays.

Main Results:

  • Nanoparticle size and CPT loading efficiency were influenced by the type of polysaccharide used.
  • Polysaccharide modification affected CPT release rates and reduced non-specific protein binding.
  • CPT-loaded nanoparticles induced significant morphological changes in 7721 cancer cells.
  • The modified nanoparticles showed minimal intrinsic cytotoxicity, but significantly enhanced the in vitro inhibition rate of CPT against liver cancer cells.

Conclusions:

  • Functional polysaccharides effectively stabilize Fe3O4 nanoparticles, creating a promising platform for CPT delivery.
  • Polysaccharide choice critically influences nanoparticle characteristics and drug delivery performance.
  • CPT-loaded polysaccharide-modified Fe3O4 nanoparticles demonstrate enhanced anti-cancer efficacy against liver cancer cells with improved safety profiles.